Bristol-Myers Squibb
BMY
BMY
1,301 hedge funds and large institutions have $57.6B invested in Bristol-Myers Squibb in 2014 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 466 increasing their positions, 535 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% less first-time investments, than exits
New positions opened: 66 | Existing positions closed: 84
25% less call options, than puts
Call options by funds: $538M | Put options by funds: $720M
35% less funds holding in top 10
Funds holding in top 10: 57 → 37 (-20)
Holders
1,301
Holding in Top 10
37
Calls
$538M
Puts
$720M
Top Buyers
| 1 | +$1.49B | |
| 2 | +$585M | |
| 3 | +$486M | |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$129M |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
+$109M |
Top Sellers
| 1 | -$603M | |
| 2 | -$401M | |
| 3 | -$259M | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$174M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$169M |